Creative Medical Technology Stock Market Value
| CELZ Stock | USD 1.83 0.06 3.17% |
| Symbol | Creative |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Creative Medical. Projected growth potential of Creative fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Creative Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 3.589 | Earnings Share (2.84) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Creative Medical Tec is measured differently than its book value, which is the value of Creative that is recorded on the company's balance sheet. Investors also form their own opinion of Creative Medical's value that differs from its market value or its book value, called intrinsic value, which is Creative Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Creative Medical's market value can be influenced by many factors that don't directly affect Creative Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Creative Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Creative Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Creative Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Creative Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Creative Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Creative Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Creative Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Creative Medical Technology or generate 0.0% return on investment in Creative Medical over 90 days. Creative Medical is related to or competes with Biocardia, Acurx Pharmaceuticals, Aprea Therapeutics, HCW Biologics, Adial Pharmaceuticals, Alzamend Neuro, and Kiora Pharmaceuticals. Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and ne... More
Creative Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Creative Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Creative Medical Technology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 25.03 | |||
| Value At Risk | (9.64) | |||
| Potential Upside | 8.61 |
Creative Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Creative Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Creative Medical's standard deviation. In reality, there are many statistical measures that can use Creative Medical historical prices to predict the future Creative Medical's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.31) |
Creative Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.30) | |||
| Mean Deviation | 3.99 | |||
| Coefficient Of Variation | (863.57) | |||
| Standard Deviation | 5.33 | |||
| Variance | 28.37 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.31) | |||
| Maximum Drawdown | 25.03 | |||
| Value At Risk | (9.64) | |||
| Potential Upside | 8.61 | |||
| Skewness | 0.3773 | |||
| Kurtosis | 0.6655 |
Creative Medical Tec Backtested Returns
Creative Medical Tec secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of standard deviation over the last 3 months. Creative Medical Technology exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Creative Medical's risk adjusted performance of (0.09), and Mean Deviation of 3.99 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.05, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Creative Medical will likely underperform. At this point, Creative Medical Tec has a negative expected return of -0.72%. Please make sure to confirm Creative Medical's total risk alpha, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if Creative Medical Tec performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Creative Medical Technology has weak predictability. Overlapping area represents the amount of predictability between Creative Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Creative Medical Tec price movement. The serial correlation of 0.24 indicates that over 24.0% of current Creative Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.